CVS Health Corporation $CVS Shares Sold by Factory Mutual Insurance Co.

Key Points

• Factory Mutual Insurance Co. cut its stake in CVS by 31.4% in Q4, selling 141,100 shares and leaving 308,143 shares valued at about $24.45 million per its latest 13F filing.
• CVS beat quarterly estimates, reporting $1.09 EPS (vs. $1.00 consensus) and $105.69 billion in revenue (up 8.2% YoY), and set FY2026 EPS guidance of 5.94–6.14.
• The company declared a quarterly dividend of $0.665 (annualized $2.66, yield 3.4%; ex-dividend April 23), although its dividend payout ratio is a high 192.75%.

Factory Mutual Insurance Co. lowered its holdings in CVS Health Corporation (NYSE:CVS - Free Report) by 31.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 308,143 shares of the pharmacy operator's stock after selling 141,100 shares during the period. Factory Mutual Insurance Co.'s holdings in CVS Health were worth $24,454,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Sei Investments Co. boosted its stake in shares of CVS Health by 17.4% in the second quarter. Sei Investments Co. now owns 905,715 shares of the pharmacy operator's stock valued at $62,474,000 after purchasing an additional 134,535 shares during the period. Investment House LLC boosted its stake in shares of CVS Health by 6.1% in the second quarter. Investment House LLC now owns 8,715 shares of the pharmacy operator's stock valued at $601,000 after purchasing an additional 500 shares during the period. The Manufacturers Life Insurance Company boosted its stake in shares of CVS Health by 1.2% in the second quarter. The Manufacturers Life Insurance Company now owns 1,121,377 shares of the pharmacy operator's stock valued at $77,353,000 after purchasing an additional 13,329 shares during the period. Treasurer of the State of North Carolina boosted its stake in shares of CVS Health by 1.3% in the second quarter. Treasurer of the State of North Carolina now owns 585,073 shares of the pharmacy operator's stock valued at $40,358,000 after purchasing an additional 7,588 shares during the period. Finally, HUB Investment Partners LLC boosted its stake in shares of CVS Health by 25.0% in the second quarter. HUB Investment Partners LLC now owns 15,063 shares of the pharmacy operator's stock valued at $1,039,000 after purchasing an additional 3,011 shares during the period. Institutional investors and hedge funds own 80.66% of the company's stock.

CVS Health Trading Up 0.6%

NYSE CVS opened at $79.29 on Friday. CVS Health Corporation has a 12 month low of $58.35 and a 12 month high of $85.15. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.84 and a quick ratio of 0.63. The company has a market capitalization of $101.61 billion, a price-to-earnings ratio of 57.45, a price-to-earnings-growth ratio of 0.82 and a beta of 0.51. The company's fifty day moving average price is $75.92 and its two-hundred day moving average price is $77.79.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, beating analysts' consensus estimates of $1.00 by $0.09. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The firm had revenue of $105.69 billion for the quarter, compared to the consensus estimate of $103.67 billion. During the same period in the prior year, the firm posted $1.19 EPS. The firm's revenue was up 8.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, research analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, May 4th. Stockholders of record on Thursday, April 23rd will be given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.4%. The ex-dividend date is Thursday, April 23rd. CVS Health's dividend payout ratio (DPR) is presently 192.75%.

Analyst Ratings Changes

Several research analysts have recently weighed in on CVS shares. Wolfe Research decreased their target price on shares of CVS Health from $100.00 to $97.00 and set an "outperform" rating for the company in a research note on Monday, March 2nd. Argus decreased their target price on shares of CVS Health from $91.00 to $90.00 and set a "buy" rating for the company in a research note on Wednesday, January 28th. Bank of America decreased their target price on shares of CVS Health from $100.00 to $95.00 and set a "buy" rating for the company in a research note on Tuesday, January 27th. Weiss Ratings restated a "hold (c-)" rating on shares of CVS Health in a research note on Monday, December 29th. Finally, Leerink Partners reiterated an "outperform" rating and set a $98.00 price objective on shares of CVS Health in a research note on Thursday, March 5th. Twenty analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, CVS Health has a consensus rating of "Moderate Buy" and an average target price of $94.95.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.